INSITRO
Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from bioengineering enabling it to generate high-throughput, functional genomic data sets and aligning them with patient data via novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics. In 2018, Daphne Koller established Insitro in South San Francisco, California..
INSITRO
Industry:
Biotechnology Life Science Machine Learning Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.insitro.com
Total Employee:
101+
Status:
Active
Total Funding:
743 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome
Similar Organizations
BenchSci
BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Numerate
Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-22 | Haystack Sciences | Haystack Sciences acquired by Insitro | N/A |
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Insitro
BlackRock
BlackRock investment in Series C - Insitro
HOF Capital
HOF Capital investment in Series C - Insitro
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board investment in Series C - Insitro
GV
GV investment in Series C - Insitro
Foresite Capital
Foresite Capital investment in Series C - Insitro
Casdin Capital
Casdin Capital investment in Series C - Insitro
Temasek Holdings
Temasek Holdings investment in Series C - Insitro
T. Rowe Price
T. Rowe Price investment in Series C - Insitro
Third Rock Ventures
Third Rock Ventures investment in Series C - Insitro
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-07 | insitro Appoints Tom Stocky as Vice President of Product |
| 2019-12-05 | insitro Expands Leadership Team with Appointment of Serafim Batzoglou as Chief Data Officer |
Official Site Inspections
http://www.insitro.com Semrush global rank: 3.02 M Semrush visits lastest month: 5.38 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Insitro"
Insitro - Crunchbase Company Profile & Funding
Organization. Insitro . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Insitro is an operator of a data-driven drug discovery and development company that utilizes machine …See details»
Our Leaders & Team Members - insitro
Achieving our bold mission requires a breathtakingly diverse team across functional disciplines, life experiences, and expertise. But the only way that we are more than the sum of those parts is by building an egalitarian, inclusive …See details»
insitro - LinkedIn
Insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.See details»
Emily Fox - insitro
Emily Fox, Ph.D., serves as our senior vice president of AI/machine learning. Emily is a professor in the Department of Statistics and Department of Computer Science at Stanford University, where she has made groundbreaking …See details»
Insitro: Discovery New Medicines with AI - Digital Innovation and ...
Nov 29, 2022 Insitro is an AI-based drug discovery company headquartered in San Francisco, CA. Founded in 2018, it has made waves in the biotech industry by merging advanced high …See details»
Better drugs through AI? Insitro CEO on what machine ... - CT Insider
Dec 2, 2024 Founded in 2018, Insitro is part of a growing field of AI companies promising to accelerate drug discovery by using machine learning to analyze huge datasets of chemical …See details»
Insitro - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Insitro . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Insitro has 5 board members and advisors, …See details»
Better drugs through AI? Insitro CEO on what machine learning …
Dec 2, 2024 Founded in 2018, Insitro is part of a growing field of AI companies promising to accelerate drug discovery by using machine learning to analyze huge datasets of chemical …See details»
Insitro - Golden
Insitro is a San Francisco-based biotechnology company with a focus on using artificial intelligence and other technologies for the research and development of drugs for medical …See details»
Exclusive: Machine Learning Company Insitro Raises $143 ... - Forbes
May 26, 2020 The deal allows Insitro to use data from Gliead’s clinical trials to train its machine learning platform. The company also focuses heavily on neuroscience, and hopes that using …See details»
insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug ...
Dec 1, 2022 Tagari joins insitro following a 24-year career at Amgen, where he has led the organization's research platforms for over a decade as vice president, research - therapeutic …See details»
Insitro - Funding, Financials, Valuation & Investors - Crunchbase
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery. Search Crunchbase. ... How much funding has this organization …See details»
Better Medicine in the Epoch of Machine Learning - insitro
We have built insitro to try and address both. Key to the deployment of powerful ML is the availability of large, high-quality, multi-modal datasets. Transformative new technologies, both …See details»
Better drugs through AI? Insitro CEO on what machine learning …
Dec 2, 2024 Founded in 2018, Insitro is part of a growing field of AI companies promising to accelerate drug discovery by using machine learning to analyze huge datasets of chemical …See details»
Better drugs through AI? Insitro CEO on what machine learning …
Dec 2, 2024 The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, …See details»
Insitro nets $143M to ramp up machine learning drug discovery
May 26, 2020 In the two years since it set up shop, insitro has been plugging away at a data- and machine learning-driven approach to drug discovery. Now, the company is picking up …See details»
Insitro raises $400M for machine learning-powered drug discovery ...
Mar 15, 2021 The artificial intelligence-powered drug discovery company insitro has secured a mammoth funding round of $400 million, to carry forward its development efforts and Big …See details»
Our Pipeline Focused On Insights & Patient Value - insitro
The insitro platform powers the discovery of new medicines for a range of therapeutic areas. We focus on diseases where machine learning can make a transformative difference, by …See details»
Katie Jackson - insitro - LinkedIn
A transformative leader with over 17 years of expertise in people strategy… · Experience: insitro · Education: Pepperdine University, The George L. Graziadio School of Business and …See details»